BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 23677154)

  • 21. Trends in AIDS-defining and non-AIDS-defining malignancies among HIV-infected patients: 1989-2002.
    Bedimo R; Chen RY; Accortt NA; Raper JL; Linn C; Allison JJ; Dubay J; Saag MS; Hoesley CJ
    Clin Infect Dis; 2004 Nov; 39(9):1380-4. PubMed ID: 15494916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Remission from Kaposi's sarcoma on HAART is associated with suppression of HIV replication and is independent of protease inhibitor therapy.
    Martinez V; Caumes E; Gambotti L; Ittah H; Morini JP; Deleuze J; Gorin I; Katlama C; Bricaire F; Dupin N
    Br J Cancer; 2006 Apr; 94(7):1000-6. PubMed ID: 16570046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV-related lung cancer -- a growing concern?
    Powles T; Nelson M; Bower M
    Int J STD AIDS; 2003 Oct; 14(10):647-51. PubMed ID: 14596765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AIDS and non-Hodgkin's lymphoma. Experience at an oncological center in Mexico.
    Cornejo-Juárez P; Volkow-Fernández P; Avilés-Salas A; Calderón-Flores E
    Rev Invest Clin; 2008; 60(5):375-81. PubMed ID: 19227434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiologic trends of cancer diagnoses among HIV-infected children in Spain from 1997 to 2008.
    Alvaro-Meca A; Micheloud D; Jensen J; Díaz A; García-Alvarez M; Resino S
    Pediatr Infect Dis J; 2011 Sep; 30(9):764-8. PubMed ID: 21494172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Malignancies in human immunodeficiency virus infected patients in India: Initial experience in the HAART era.
    Sharma SK; Soneja M; Ranjan S
    Indian J Med Res; 2015 Nov; 142(5):563-7. PubMed ID: 26658591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term survival of HIV-infected patients treated with highly active antiretroviral therapy in Serbia and Montenegro.
    Jevtović DO; Salemović D; Ranin J; Pesić I; Zerjav S; Djurković-Djaković O
    HIV Med; 2007 Mar; 8(2):75-9. PubMed ID: 17352762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spectrum of AIDS defining & non-AIDS defining malignancies in north India.
    Sachdeva RK; Sharma A; Singh S; Varma S
    Indian J Med Res; 2016 May; 143(Supplement):S129-S135. PubMed ID: 27748287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Malignancies in HIV: pre- and post-highly active antiretroviral therapy.
    Nutankalva L; Wutoh AK; McNeil J; Frederick WR; Reddy RB; Daftary M; Gentles A; Addae-Afoakwa K
    J Natl Med Assoc; 2008 Jul; 100(7):817-20. PubMed ID: 18672558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Incidence variation in malignancies associated or not with AIDS at an outpatient care center, 1997-2005].
    Laurido M; Urueña A; Vizzotti C; Bugarin G; Cassetti I
    Medicina (B Aires); 2007; 67(3):243-6. PubMed ID: 17628911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [High incidence of non-AIDS-defined cancers among HIV-infected patients in Germany. A 3-year nationwide review].
    Mosthaf FA; Hanhoff NJ; Goetzenich A; Wolf E; Knechten H
    Dtsch Med Wochenschr; 2006 Aug; 131(34-35):1849-52. PubMed ID: 16915544
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Epidemiology of HIV-associated malignancies].
    Launay O; Guillevin L
    Bull Cancer; 2003 May; 90(5):387-92. PubMed ID: 12850760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic.
    Ives NJ; Gazzard BG; Easterbrook PJ
    J Infect; 2001 Feb; 42(2):134-9. PubMed ID: 11531320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term complications in patients with poor immunological recovery despite virological successful HAART in Dutch ATHENA cohort.
    van Lelyveld SF; Gras L; Kesselring A; Zhang S; De Wolf F; Wensing AM; Hoepelman AI;
    AIDS; 2012 Feb; 26(4):465-74. PubMed ID: 22112603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Malignancies in HIV: the Indian scenario.
    Dhir AA; Sawant SP
    Curr Opin Oncol; 2008 Sep; 20(5):517-21. PubMed ID: 19106653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children.
    Sánchez JM; Ramos Amador JT; Fernández de Miguel S; González Tomée MI; Rojo Conejo P; Ferrnado Vivas P; Clemente Vivas J; Ruiz Contreras J; Nogales Espert A
    Pediatr Infect Dis J; 2003 Oct; 22(10):863-7. PubMed ID: 14551485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [AIDS-associated Kaposi's sarcoma: 22 cases].
    Dhrif AS; Kilani B; Ammari L; Kanoun F; Tiouri H; Ben Chaaben T
    Tunis Med; 2007 Jun; 85(6):494-9. PubMed ID: 17644904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiological and clinical features, response to HAART, and survival in HIV-infected patients diagnosed at the age of 50 or more.
    Nogueras M; Navarro G; Antón E; Sala M; Cervantes M; Amengual M; Segura F
    BMC Infect Dis; 2006 Nov; 6():159. PubMed ID: 17087819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence and causes of death in HIV-infected persons receiving highly active antiretroviral therapy compared with estimates for the general population of similar age and from the same geographical area.
    Martínez E; Milinkovic A; Buira E; de Lazzari E; León A; Larrousse M; Loncá M; Laguno M; Blanco JL; Mallolas J; García F; Miró JM; Gatell JM
    HIV Med; 2007 May; 8(4):251-8. PubMed ID: 17461853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV/AIDS associated malignancies of the head and neck.
    Bunn BK; van Heerden WF
    SADJ; 2012 Nov; 67(10):590-2. PubMed ID: 23957103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.